1. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts.
- Author
-
Ohnaka K, Tanabe M, Kawate H, Nawata H, and Takayanagi R
- Subjects
- Active Transport, Cell Nucleus, Adjuvants, Immunologic pharmacology, Calcitriol metabolism, Cell Line, Cell Nucleus metabolism, Cytosol metabolism, Dexamethasone pharmacology, Dose-Response Relationship, Drug, Genes, Reporter, Genetic Vectors metabolism, Green Fluorescent Proteins metabolism, Humans, Lithium Chloride pharmacology, Microscopy, Confocal, Osteoporosis, Plasmids metabolism, Proteins metabolism, Subcellular Fractions metabolism, Transcription, Genetic, Transcriptional Activation, Transfection, Wnt Proteins, Wnt3 Protein, Wnt3A Protein, Glucocorticoids metabolism, Intercellular Signaling Peptides and Proteins metabolism, Osteoblasts metabolism
- Abstract
To explore the mechanism of glucocorticoid-induced osteoporosis, we investigated the effect of glucocorticoid on canonical Wnt signaling that emerged as a novel key pathway for promoting bone formation. Wnt3a increased the T-cell factor (Tcf)/lymphoid enhancer factor (Lef)-dependent transcriptional activity in primary cultured human osteoblasts. Dexamethasone suppressed this transcriptional activity in a dose-dependent manner, while 1,25-dihydroxyvitamin D3 increased this transcriptional activity. LiCl, an inhibitor of glycogen synthase kinase-3beta, also enhanced the Tcf/Lef-dependent transcriptional activity, which was, however, not inhibited by dexamethasone. The addition of anti-dickkopf-1 antibody partially restored the transcriptional activity suppressed by dexamethasone. Dexamethasone decreased the cytosolic amount of beta-catenin accumulated by Wnt3a and also inhibited the nuclear translocation of beta-catenin induced by Wnt3a. These data suggest that glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts, partially through the enhancement of the dickkopf-1 production.
- Published
- 2005
- Full Text
- View/download PDF